4 active warrant series; nearest expiry 2027-06-19.
Compare this book against every issuer →4 option grants covering 7,362,739 shares (~7.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.50 | Jun 19, 2027 265d | 530K | OTM | 0.6% | C$794K | Auto |
| option | $14.75 | Mar 19, 2028 539d | 2.9M | OTM | 3.1% | C$42.9M | Auto |
| option | $3.08 | Oct 3, 2028 737d | 2.6M | OTM | 2.8% | C$8.1M | Auto |
| option | $7.23 | Nov 30, 2028 795d | 1.3M | OTM | 1.4% | C$9.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
92,819,788 shares outstanding, plus 0 from warrants and 7,362,739 from options — a fully diluted 100,182,527 shares, or ~7.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series; nearest expiry 2027-06-19.
Compare this book against every issuer →4 option grants covering 7,362,739 shares (~7.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.50 | Jun 19, 2027 265d | 530K | OTM | 0.6% | C$794K | Auto |
| option | $14.75 | Mar 19, 2028 539d | 2.9M | OTM | 3.1% | C$42.9M | Auto |
| option | $3.08 | Oct 3, 2028 737d | 2.6M | OTM | 2.8% | C$8.1M | Auto |
| option | $7.23 | Nov 30, 2028 795d | 1.3M | OTM | 1.4% | C$9.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
92,819,788 shares outstanding, plus 0 from warrants and 7,362,739 from options — a fully diluted 100,182,527 shares, or ~7.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
